Drug intelligence / Profile preview

CLn BodyWash

Development stage: Unknown
Lead developer: CLn Skin Care
Administration: Topical

Overview

CLn BodyWash is a dermatologist-designed cleanser formulated for compromised skin prone to eczema, dermatitis, rashes, folliculitis, hidradenitis suppurativa (HS), and other skin irritations. The key active ingredient is sodium hypochlorite (bleach) in a low concentration, which effectively cleanses skin and helps decrease the spread of infection without causing irritation or exacerbating dryness. Clinical studies show it can reduce the appearance of skin redness, dryness, and flakiness seen with eczema when used for 2 minutes daily in as few as 2-3 weeks. The product is fragrance-free, paraben-free, hypoallergenic, and cruelty-free, and has received the National Eczema Association Seal of Acceptance.

Brand names: CLn BodyWash

Beyond the preview

Go deeper on CLn BodyWash.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CLn BodyWash.

Explore the full profile